Overview
CAH market data
Price History
CAH price chart
Valuation & Profitability
- P/E (TTM)
- 34.65 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $6.45 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.49 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 0.9% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 0.6% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $145.47 – $258.30 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $53.9B · P/B 9.25 · P/S 0.21.
Company News
TD Cowen Maintains Buy on Cardinal Health, Raises Price Target to $280Benzinga · Aug 13, 2026, 4:40 PM
JP Morgan Maintains Neutral on Cardinal Health, Raises Price Target to $260Benzinga · Aug 13, 2026, 3:00 PM
Barclays Maintains Overweight on Cardinal Health, Raises Price Target to $275Benzinga · Aug 13, 2026, 2:02 PM
Evercore ISI Group Maintains Outperform on Cardinal Health, Raises Price Target to $270Benzinga · Aug 12, 2026, 4:06 PM
Morgan Stanley Maintains Overweight on Cardinal Health, Raises Price Target to $265Benzinga · Aug 12, 2026, 3:50 PM
Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $250Benzinga · Aug 12, 2026, 1:50 PM
UBS Maintains Buy on Cardinal Health, Raises Price Target to $280Benzinga · Aug 12, 2026, 1:13 PM
Cardinal Health Analysts Increase Their Forecasts Following Q4 ResultsBenzinga · Aug 12, 2026, 12:28 PM
Wells Fargo Maintains Overweight on Cardinal Health, Raises Price Target to $277Benzinga · Aug 12, 2026, 12:20 PM
Baird Maintains Outperform on Cardinal Health, Raises Price Target to $274Benzinga · Aug 12, 2026, 10:28 AM